Astronauts return to Earth with SpaceX after 5 months at the International Space Station
Their SpaceX capsule parachuted into the Pacific off the Southern California coast a day after departing the orbiting lab.
'Welcome home,' SpaceX Mission Control radioed.
Splashing down were NASA's Anne McClain and Nichole Ayers, Japan's Takuya Onishi and Russia's Kirill Peskov. They launched in March as replacements for the two NASA astronauts assigned to Starliner's botched demo.
Starliner malfunctions kept Butch Wilmore and Suni Williams at the space station for more than nine months instead of a week. NASA ordered Boeing's new crew capsule to return empty and switched the pair to SpaceX. They left soon after McClain and her crew arrived to take their places. Wilmore has since retired from NASA.
Before leaving the space station on Friday, McClain made note of 'some tumultuous times on Earth' with people struggling.
'We want this mission, our mission, to be a reminder of what people can do when we work together, when we explore together,' she said.
McClain looked forward to 'doing nothing for a couple of days' once back home in Houston. High on her crewmates' wish list: hot showers and juicy burgers.
It was SpaceX's third Pacific splashdown with people on board, but the first for a NASA crew in 50 years. Elon Musk's company switched capsule returns from Florida to California's coast earlier this year to reduce the risk of debris falling on populated areas. Back-to-back private crews were the first to experience Pacific homecomings.
The last time NASA astronauts returned to the Pacific from space was during the 1975 Apollo-Soyuz mission, a détente meet-up of Americans and Soviets in orbit.
___
The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Department of Science Education and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.
Solve the daily Crossword
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Medscape
43 minutes ago
- Medscape
Multiple Chronic Conditions Tied to Poor Prognosis in RA
TOPLINE: In patients with rheumatoid arthritis (RA), the presence of multiple chronic conditions was associated with an increased likelihood of disease flare and reduced odds of achieving remission. METHODOLOGY: Researchers conducted a retrospective, population-based study to investigate how multiple chronic conditions and adverse social determinants of health influence disease activity in patients with RA. They analyzed the data of 659 patients with incident RA diagnosed between January 1999 and December 2014 (median age, 55.3 years; 69.7% women); each participant was required to have complete medical history of at least 1 year. A list of 55 chronic medical conditions was used to identify multimorbidity (two or more conditions) and substantial multimorbidity (five or more conditions); the burden of adverse social determinants of health was assessed using the Area Deprivation Index and Social Vulnerability Index, considering factors such as socioeconomic status, housing quality, and education, among others. Flare was identified as a worsening of disease requiring initiation, change, or escalation of treatment; remission was identified as having no more than one tender or swollen joint and normal inflammatory markers The patients were followed for a median duration of 10.3 years and had a median number of 13 RA-related visits during the follow-up period. TAKEAWAY: Among the participants, 73.3% of patients had multimorbidity and 36.1% had substantial multimorbidity. Patients with multimorbidity had 29% higher odds of an RA-related visit for disease flare and those with substantial multimorbidity had 26% higher odds (P < .05 for both); multimorbidity and substantial multimorbidity were also associated with significantly lower odds of a visit due to remission (odds ratios, 0.66 and 0.67, respectively; P < .05 for both). Each 0.1 increase in the Social Vulnerability Index above 0.3 was associated with 8% lower odds of achieving remission (P < .05). Female sex, current smoking, younger age, and shorter disease duration were associated with higher odds of a flare visit; on the contrary, male sex, never smoking, and longer disease duration were associated with higher odds of a remission visit. Seropositivity showed no significant association with either outcome. IN PRACTICE: 'Multimorbidity shows potential to act as a prognostic factor for RA disease activity and can be readily adapted to real-world clinical settings. Increased attention to multimorbidity would help identify patients at risk of poor disease control, signaling to clinicians to consider more aggressive intervention early on,' the authors of the study wrote. SOURCE: This study was led by Daniel Montes, MD, Mayo Clinic, Rochester, Minnesota. It was published online on August 5, 2025, in RMD Open. LIMITATIONS: This retrospective study relied on diagnostic codes for identifying comorbidities. The use of disease-modifying antirheumatic drugs could not be accounted for. The study population was predominantly White (88%), limiting generalizability. DISCLOSURES: This study was supported by grants from the National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases, and National Institute on Aging. One author reported receiving intellectual property/patents from Girhilet, NLC Health Ventures, and Remission Medical and grant/research support from Pfizer. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
Yahoo
an hour ago
- Yahoo
The Perseid meteor shower is peaking Tuesday. Here's how to see it
It's finally time to watch one of the best meteor showers of the year: the brilliant display known as the Perseids. The Perseid meteor shower, which is known for producing dozens of bright meteors that leave long streaks in their wake, peaked at 4 p.m. ET Tuesday. In previous years, it produced around 40 to 50 visible meteors per hour, but sky-gazers likely won't see as many this year, said Bill Cooke, the lead for NASA's Meteoroid Environments Office. This is due to the fact that the Perseid shower is occurring shortly after August's full moon. The moon will be in a waning gibbous phase and at around 85% illumination, which means the light from the moon will make meteor-spotting more difficult. According to experts, you may see around 10 to 20 meteors per hour. When to watch for meteors While the peak of the Perseids happened well before sunset in the US, there are two windows of time between Tuesday night and Wednesday morning during which stargazers should aim to be outside for the best chance of glimpsing a meteor. 'Between dusk and moonrise on the evening of August 12, there's going to be a one-hour gap before the moon rises,' when you can look for Perseid activity, said Robert Lunsford, fireball report coordinator for the American Meteor Society. These meteors shoot out in all directions from the constellation Perseus, which is located in the northern sky. Lunsford noted, however, that, due to Perseus appearing low on the horizon at this time, much of the meteor activity will be blocked from view. 'Any meteors you do see at that time are going to be called Earth grazers because they can just graze the upper atmosphere,' he said. While most Perseid meteors are visible for mere milliseconds, the few earth grazers you might spot 'will be very long and will last two or three seconds,' he added. The last couple of hours before daybreak on Wednesday is the other window during which Lunsford recommends trying to see the shower. 'There'll be a bright moon up in the southern sky, but if you turn your gaze northward and look kind of toward the constellation Perseus, you can still see the brighter meteors.' Look up for planets The peak of the Perseids is occurring just after the conjunction of Venus and Jupiter, and the two planets will still be close together and shining brightly. The best views will be in the eastern sky before sunrise. 'These are the two brightest planets,' Lunsford said. 'This (conjunction) happens about once a year, but it's still spectacular when you get the two brightest planets really close to each other.' Saturn will also be joining the night's celestial display in the late evening hours on Tuesday. It will appear near the moon and will rise before midnight, according to EarthSky. Upcoming meteor showers Here are the peak dates of other meteor showers anticipated in 2025, according to the American Meteor Society and EarthSky. Draconids: October 8-9 Orionids: October 22-23 Southern Taurids: November 3-4 Northern Taurids: November 8-9 Leonids: November 16-17 Geminids: December 13-14 Ursids: December 21-22 Upcoming full moons Look out for four more full moons this year, with supermoons occurring in October, November and December. Their dates are: September 7 October 6 November 5 December 4 Lunar and solar eclipses in 2025 Two eclipse events will take place as summer draws to a close. A total lunar eclipse will be visible in Europe, Asia, Australia, Africa, parts of eastern South America, Alaska and Antarctica on September 7 and 8, according to Time and Date. A lunar eclipse occurs when the moon passes directly into Earth's shadow as the sun, Earth and the moon line up. This causes the moon to appear darker or dimmed. When the moon sits in the darkest part of Earth's shadow, the sun's rays peek out from behind Earth and the light refracts, giving the moon a reddish hue, according to London's Natural History Museum. Some people call the result a 'blood moon.' Two weeks later, on September 21, a partial solar eclipse will be visible in parts of Australia, the Atlantic, the Pacific and Antarctica. Solar eclipses occur when the moon moves between the sun and Earth. In the case of a partial solar eclipse, the moon does not fully block out the sun. It creates a crescent — as if the moon took a bite out of the sun. Sign up for CNN's Wonder Theory science newsletter. Explore the universe with news on fascinating discoveries, scientific advancements and more. Solve the daily Crossword
Medscape
an hour ago
- Medscape
Pediatric-to-Adult HIV Transition Model Shows Mixed Results
TOPLINE: The Adolescent and Young Adult (AYA) Healthcare Transition (HCT) clinic — a pediatric-to-adult HIV care model — achieved a high 1-year retention rate but a suboptimal viral suppression rate despite high engagement in care. Ryan White funding and program adaptability emerged as key strengths, while the region's political climate and HIV stigma remained as major barriers. METHODOLOGY: AYAs with HIV infection transitioning to adult care face challenges such as low retention and poor viral suppression; AYAHCT clinic was designed to address these issues and improve health outcomes in this population. Researchers conducted a mixed-methods analysis to evaluate the design, implementation, and early clinical outcomes of the AYAHCT clinic set up within the Adolescent and Young Adult Health Clinic in the Southeastern US. Quantitative analysis included 18 patients with HIV infection (mean age at first visit, 19.8 years; 78% boys) retrospectively assessed for clinical outcomes including clinic visit attendance, viral suppression, and retention in care. Qualitative analysis included nine semistructured interviews with key stakeholders in pediatric, AYAHCT, and adult HIV clinics to address facilitators of and barriers to clinic implementation. TAKEAWAY: Patients in the AYAHCT clinic averaged 4.4 visits per year, achieved 100% retention in care after 1 year, and had a viral suppression rate of 79.3%. Among the seven patients who transitioned from the AYAHCT clinic to adult care, retention remained high at 85.7%, with viral suppression improved to 96.8%. Key facilitators of clinic implementation included Ryan White funding, strong community connections, positive attitudes among providers and staff, and program adaptability. Major barriers were HIV-related stigma, the region's political climate, clinic workflow challenges, and adverse social determinants of health. IN PRACTICE: 'Our study described an innovative care model to improve AYA retention in HIV care, with future opportunities to improve VL [viral load] suppression,' the authors wrote. SOURCE: This study was led by Nina E. Hill, University of Michigan, Ann Arbor, Michigan. It was published online on July 21, 2025, in AIDS Care. LIMITATIONS: This study was limited by its small sample size, affecting the generalizability of the findings. The HIV care model involving both adolescent medicine and HIV specialists may not have been applicable to all settings. Long-term follow-up after transition to the adult HIV clinic was limited. DISCLOSURES: This study was supported by the Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center. The authors reported having no potential conflicts of interest. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
